I am a LT holder of a2m since the early days and involved in the science behind the product professionally since 10 years.
My Vision:
1. A1 Betacasein will be targeted as a major source for human diseases (A1-intolerance/lactose-intolerance are peanuts)
2. Just China has about 800 mio people as potential milk drinkers which are able to digest milk from A2A2 cows
3. Increase in Diabetes type 1 in Chinese children will move 90 % of non-breastfeeding moms to a2m-products and away from other brands
4. SEA, Africa, South America, seen as areas with 80 - 100 % lactose-intolerant people make a further 2 billion potential clients
5. The Dairy Industry will change its mind only slowly to reduce the loss of face (think about the attacks of Fonterra)
6. The competitors need at least 2 - 3 years to start "big" with a product name different to a2. This advantage has a huge impact on the share price in the near future but also makes a2m a target to really big Players (Nestlé, Kraft Foods, Unilever, etc.)
7. Milk has the potential to be the "protein-source" for a fast growing global population
8. In 20 years time 90 % of the dairy cows in the world will be A2A2 - then a2m has to create something new to sell its milk
- Forums
- ASX - By Stock
- A2M
- What is your vision for a2m?
A2M
the a2 milk company limited
Add to My Watchlist
0.25%
!
$7.99

What is your vision for a2m?
-
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$7.99 |
Change
-0.020(0.25%) |
Mkt cap ! $5.784B |
Open | High | Low | Value | Volume |
$8.04 | $8.10 | $7.90 | $13.12M | 1.641M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5600 | $7.93 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$8.00 | 11966 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5600 | 7.930 |
4 | 12374 | 7.920 |
2 | 8755 | 7.910 |
4 | 14015 | 7.900 |
1 | 3172 | 7.880 |
Price($) | Vol. | No. |
---|---|---|
8.000 | 8374 | 5 |
8.010 | 5600 | 1 |
8.020 | 20909 | 4 |
8.030 | 5600 | 1 |
8.040 | 1282 | 1 |
Last trade - 16.19pm 01/07/2025 (20 minute delay) ? |
Featured News
A2M (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Dr. Steven Gourlay, CEO
Dr. Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online